{
    "organizations": [],
    "uuid": "4043b110a03781c1ad8fa05916bc9f94925bd2d0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-merus-and-vall-dhebron-institute-o/brief-merus-and-vall-dhebron-institute-of-oncology-announce-research-collaboration-idUSFWN1R20CX",
    "ord_in_thread": 0,
    "title": "BRIEF-Merus And Vall d'Hebron Institute Of Oncology Announce Research Collaboration",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 2:00 PM / Updated 14 minutes ago BRIEF-Merus And Vall d'Hebron Institute Of Oncology Announce Research Collaboration Reuters Staff 1 Min Read March 20 (Reuters) - Merus Nv: * MERUS AND VALL Dâ€™HEBRON INSTITUTE OF ONCOLOGY ANNOUNCE RESEARCH COLLABORATION TO DEVELOP INNOVATIVE BISPECIFIC ANTIBODIES FOR THERAPEUTIC APPLICATIONS IN TREATMENT OF CANCER Source text for Eikon: Further company coverage:",
    "published": "2018-03-20T15:59:00.000+02:00",
    "crawled": "2018-03-20T16:24:06.031+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "vall",
        "institute",
        "oncology",
        "announce",
        "research",
        "collaboration",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "merus",
        "nv",
        "merus",
        "vall",
        "hebron",
        "institute",
        "oncology",
        "announce",
        "research",
        "collaboration",
        "develop",
        "innovative",
        "bispecific",
        "antibody",
        "therapeutic",
        "application",
        "treatment",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}